0001415889-23-006920.txt : 20230426
0001415889-23-006920.hdr.sgml : 20230426
20230426161705
ACCESSION NUMBER: 0001415889-23-006920
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230424
FILED AS OF DATE: 20230426
DATE AS OF CHANGE: 20230426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAUKIEN FRANK H
CENTRAL INDEX KEY: 0001133649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 23849958
MAIL ADDRESS:
STREET 1: C/O BRUKER DALTONICS
STREET 2: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
4
1
form4-04262023_080453.xml
X0407
4
2023-04-24
0001109354
BRUKER CORP
BRKR
0001133649
LAUKIEN FRANK H
C/O BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
true
true
true
false
PRESIDENT & CEO
1
Common Stock
2023-04-24
4
S
0
146122
81.01
D
38352034
D
Common Stock
2023-04-24
4
S
0
2108
81.65
D
38349926
D
Common Stock
2023-04-25
4
S
0
13793
77.87
D
38298156
D
Common Stock
2023-04-25
4
S
0
30343
79.06
D
38269921
D
Common Stock
2023-04-25
4
S
0
7174
79.82
D
38262747
D
Common Stock
2023-04-25
4
S
0
460
80.64
D
38262287
D
Common Stock
1046499
I
By Former Spouse
Common Stock
337087
I
By Son
Common Stock
336607
I
By Daughter
Common Stock
201702
I
As UTMA Custodian for Son
Common Stock
71728
I
As UTMA Custodian for Son
Common Stock
492
I
By Former Spouse
The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.57 to $81.52, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.585 to $81.93, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.51 to $78.45, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.515 to $79.50, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.51 to $80.35, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.58 to $80.67, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ Michael Simone, Attorney-in-Fact
2023-04-26